Regenerative and therapeutic effects of heparin-binding epidermal growth factor-like growth factor on diabetes by gene transduction through retrograde pancreatic duct injection of adenovirus vector

Pancreas

Volumn 31, Issue 1, 2005, Pages 32-42

  Kozawa, Junji ^a   Tokui, Yae ^a   Moriwaki, Makoto ^b   Li, Ming ^c   Ohmoto, Hiroshi ^d   Yuan, Ming ^a   Zhang, Jun ^a   Iwahashi, Hiromi ^a   Imagawa, Akihisa ^e   Yamagata, Kazuya ^a   Tochino, Yoshihiro ^a   Shimomura, Iichiro ^a   Higashiyama, Shigeki ^f   Miyagawa, Jun Ichiro ^a,g  

^a OSAKA UNIVERSITY   (Japan)

^b Minoo City Hospital   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d Nippon Organon KK   (Japan)

^e OSAKA MEDICAL COLLEGE   (Japan)

^f EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

cell; Adenovirus vector; Differentiation; Duct cell; HB EGF; Regeneration

Indexed keywords

ADENOVIRUS VECTOR; BROXURIDINE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIABETES MELLITUS; GENE CONSTRUCT; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; GLUCOSE TOLERANCE TEST; HUMAN; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS DUCT; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FAMILY; STEM CELL; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; BODY WEIGHT; BROMODEOXYURIDINE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; EPIDERMAL GROWTH FACTOR; GENE THERAPY; GLUCOSE TOLERANCE TEST; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; INJECTIONS; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED ICR; PANCREATIC DUCTS; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS;

EID: 21344446309     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000163177.59920.f8     Document Type: Article

References (41)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230-238.
2. Assady S, Maor G, Amit M, et al. Insulin production by human embryonic stem cells. Diabetes. 2001;50:1691-1697.
3. Dor Y, Brown J, Martinez OI, et al. Adult pancreatic β-cells are formed by self-duplication rather than stem cell differentiation. Nature. 2004;429:41-46.
4. Waguri M, Yamamoto K, Miyagawa J, et al. Differentiation of two different processes of β-cell regeneration in a new diabetic mouse model induced by selective perfusion of alloxan. Diabetes. 1997;46:1281-1290.
5. Yamamoto K, Miyagawa J, Itoh N, et al. Differentiation of β-cells from ductal cells and acceleration of this process by nicotinamide: ultrastructural study on the non-obese diabetic (NOD) mice with overt diabetes. Biomed Res. 1997;18:171-178.
6. Wang RN, Kloppel G, Bouwens L. Duct-to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rat. Diabetologia. 1995;38:1405-1411.
7. Rosenberg L, Vinik AI, Pittenger GL, et al. Islet-cell regeneration in the diabetic hamster pancreas with restoration of normoglycaemia can be induced by a local growth factor(s). Diabetologia. 1996;39:256-262.
8. Gu D, Lee MS, Krahl T, et al. Transitional cells in the regenerating pancreas. Development. 1994;120:1873-1881.
9. Yamamoto K, Miyagawa J, Waguri M, et al. Recombinant human betacellulin promotes the neogenesis of β-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusion. Diabetes. 2000;49:2021-2027.
10. Li M, Miyagawa J, Yamamoto K, et al. β cell neogenesis from ducts and phenotypic conversion of residual islet cells in the adult pancreas of glucose intolerant mice induced by selective alloxan perfusion. Endocr J. 2002;49:561-572.
11. Li M, Miyagawa J, Moriwaki M, et al. Analysis of expression profiles of islet-associated transcription and growth factors during β-cell neogenesis from duct cells in partially duct-ligated mice. Pancreas. 2003;27:345-355.
12. Higashiyama S, Abraham JA, Miller J, et al. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science. 1991;251:936-939.
13. Higashiyama S, Abraham JA, Klagsbrun M. Structure of heparin-binding EGF-like growth factor. J Biol Chem. 1992;267:6205-6212.
14. Kaneto H, Miyagawa J, Kajimoto Y, et al. Expression of heparin-binding epidermal growth factor-like growth factor during pancreas development. J Biol Chem. 1997;272:29137-29143.
15. Jonsson J, Carlsson L, Edlund T, et al. Insulin-promotor-factor 1 is required for pancreas development in mice. Nature. 1994;371:606-609.
16. Campbell SC, Macfarlane WM. Regulation of the pdxl gene promoter in pancreatic β-cells. Biochem Biophys Res Commun. 2002;299:277-284.
17. Miyagawa J, Higashiyama S, Kawata S, et al. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J Clin Invest. 1995;95:404-411.
18. Watada H, Kajimoto Y, Umayahara Y, et al. The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells. Diabetes. 1996;45:1478-1488.
19. Watada H, Kajimoto Y, Miyagawa J, et al. PDX-1 induces insulin and glucokinase gene expression in αTC1 clone 6 cells in the presence of betacellulin. Diabetes. 1996;45:1826-1831.
20. Kajimoto Y, Watada H, Matsuoka T, et al. Suppression of transcription factor PDX-1/IPF1/STF-1/IDX-1 causes no decrease in insulin mRNA in M1N6 cells. J Clin Invest. 1997;100:1840-1846.
21. Yi ES, Yin S, Harclerode DL, et al. Keratinocyte growth factor induces pancreatic ductal epithelial proliferation. Am J Pathol. 1994;145:80-85.
22. Miyazaki S, Yamato E, Miyazaki J. Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells. Diabetes. 2004;53:1030-1037.
23. Miettinen PJ, Heikinheimo K. Transforming growth factor-α (TGF-α) and insulin gene expression in human fetal pancreas. Development. 1992;114:833-840.
24. Sanvito F, Herrera PL, Huarte J, et al. TGF-β1 influences the relative development of the exocrine and endocrine pancreas in vitro. Development. 1994;120:3451-3462.
25. Otonkoski T, Beattie GM, Rubin JS, et al. Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes. 1994;43:947-953.
26. Kanaka-Gantenbein C, Dicou E, Czernichow P, et al. Presence of nerve growth factor and its receptors in an in vitro model of islet cell development: implication in normal islet morphogenesis. Endocrinology. 1995;136:3154-3162.
27. Taniguchi H, Yamato E, Tashiro F, et al. β cell neogenesis induced by adenovirus-mediated gene delivery of transcription factor pdx-1 into mouse pancreas. Gene Ther. 2003;10:15-23.
28. Nishida M, Miyagawa J, Yamashita S, et al. Localization of CD9, an enhancer protein for proheparin-binding epidermal growth factor-like growth factor, in human atherosclerotic plaques: possible involvement of juxtacrine growth mechanism on smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol. 2000;20:1236-1243.
29. Higashiyama S, Iwamoto R, Goishi K, et al. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol. 1995;128:929-938.
30. Goishi K, Higashiyama S, Klagsbrun M, et al. Phorbol ester induces the rapid processing of cell surface heparin-binding epidermal growth-factor like growth factor: Conversion from juxtacrine to paracrine growth factor activity. Mol Biol Cell. 1995;6:967-980.
31. Iwamoto R, Mekada E. Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev. 2000;11:335-344.
32. Bonner-Weir S. Islet growth and development in the adult. J Mol Endocrinol. 2000;24:297-302.
33. Means AL, Ray KC, Singh AB, et al. Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia. Gastroenterology. 2003;124:1020-1036.
34. Matsumoto S, Kishida K, Shimomura I, et al. Increased plasma HB-EGF associated with obesity and coronary artery disease. Biochem Biophys Res Commun. 2002;292:781-786.
35. Reynolds CM, Eguchi S, Frank GD, et al. Signaling mechanisms of heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells. Hypertension. 2002;39:525-529.
36. Inui Y, Higashiyama S, Kawata S, et al. Expression of heparin-binding epidermal growth factor in human hepatocellular carcinoma. Gastroenterology. 1994;107:1799-1804.
37. Ito Y, Takeda T, Higashiyama S, et al. Expression of heparin-binding epidermal growth factor-like growth factor in hepatocellular carcinoma: an immunohistochemical study. Oncol Rep. 2001;8:903-907.
38. Kobrin M, Funatomi H, Friess H, et al. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem Biophys Res Commun. 1994;202:1705-1709.
39. Ito Y, Higashiyama S, Takeda T, et al. Expression of heparin-binding epidermal growth factor-like growth factor in pancreatic adenocarcinoma. Int J Pancreatol. 2001;29:47-52.
40. Murayama Y, Miyagawa J, Shinomura Y, et al. Significance of the association between heparin-binding epidermal growth factor-like growth factor and CD9 in human gastric cancer. Int J Cancer. 2002;98:505-513.
41. Ito Y, Takeda T, Higashiyama S, et al. Expression of heparin-binding epidermal growth factor-like growth factor in breast carcinoma. Breast Cancer Res Treat. 2001;67:81-85.